BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Avantium Technologies Further Strengthens its Pharma Business Development Team


11/21/2008 12:04:53 PM

AMSTERDAM, The Netherlands, November 18 /PRNewswire/ -- Avantium Technologies announced today that Bernard Mulder, MD, MBA, has joined Avantium to lead the business development team for its pharmaceutical business.

Bernard Mulder, Global Vice President Business Development Pharma, will be responsible for Avantium's pharmaceutical service business world-wide. The previous 12 years of his career, Bernard held several international positions at Organon. Before joining Avantium, he was commercially responsible for the Asenapine Global Venture Team. Bernard's experience, commercial skills and drive will help Avantium to take Avantium's pharmaceutical business to the next level.

"Bernard is a great addition to the team. He will contribute very significant international, commercial experience and he has a profound understanding of our pharmaceutical industry customers. With Bernard and his team we will be able to better address and meet the diverse needs of our pharmaceutical customer base," says Guus Scheefhals, Chief Business Officer of Avantium Technologies. "I am very pleased that we managed to get Bernard Mulder on our team. Bernard's capabilities and personality as well as his experience of working in the pharmaceutical industry make him a great contribution to the company."

Profile Avantium

Avantium is a leading technology company in the area of advanced high-throughput R&D operating in the energy, chemicals and pharmaceutical industries. The company develops products and processes in the area of biofuels, bio-based chemicals and novel crystal forms of existing drugs by applying its proprietary, high-throughput R&D technology. Avantium has demonstrated the potential of this technology by providing R&D services and tools to more than 70 companies worldwide. Avantium's customer base includes many of the world's largest energy, chemicals and pharmaceutical companies, such as BP, Shell, Sasol, Pfizer and GSK. Avantium has approximately 130 employees; its offices and head quarters are based in Amsterdam, the Netherlands.

http://www.avantium.com

CONTACT: For further information: Please contact: Mariette Hoogendoorn at
+31-20-586-8010



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES